Search research articles
Contact Us
Filters
Showing results (81-90 of 267) with videos related to
Page
of 27
Sort By:
Revue Medicale De Liege
|
February 2, 1999
[Clinical case of the month. A case of Munchausen syndrome (factitious disorder)]
K Kjiri, A Ajamieh, M Hansenne, et al.
Regulatory Peptides
|
April 29, 1993
Neurohypophyseal peptides and psychiatric diseases
J J Legros, M Ansseau, M Timsit-Berthier
Revue Medicale De Liege
|
August 6, 2010
[Recovering from depression: a matter of objective and determination]
W Pitchot, G Scantamburlo, E Pinto, et al.
Acta Psychiatrica Belgica
|
September 1, 1980
Biochemical and neuroendocrine approaches to a malignant syndrome of neuroleptics
M Ansseau, S Diricq, T Grisar, et al.
Acta Psychiatrica Belgica
|
September 1, 1983
Pilot study of a specific serotonergic antagonist, pirenperone, in the treatment of anxiety disorders
M Ansseau, A Doumont, D Thiry, et al.
Brain Research. Brain Research Reviews
|
November 10, 2005
Dopamine-glutamate reciprocal modulation of release and motor responses in the rat caudate-putamen and nucleus accumbens of "intact" animals
Hélène N David, Marc Ansseau, Jacques H Abraini
Revue Medicale De Liege
|
August 2, 2008
[The electroconvulsive therapy in 2008]
S Servais, M Ansseau, G Mikolajczak, et al.
Journal of Psychopharmacology (Oxford, England)
|
December 31, 2002
Venlafaxine: the relationship between dose, plasma concentration and clinical response in depressive patients
C Charlier, E Pinto, M Ansseau, et al.
Revue Medicale De Liege
|
March 13, 2010
[Inappropriate antidiuretic hormone secretion induced by sodium valproate]
E Bève, E Beck, E Pinto, et al.
Journal of Clinical Psychopharmacology
|
July 31, 2001
Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features
J D Guelfi, M Ansseau, L Timmerman, et al.
Page
of 27
Search research articles
Search
Showing results (81-90 of 267) with videos related to
Sort By:
Page
of 27
Revue Medicale De Liege
|
February 2, 1999
[Clinical case of the month. A case of Munchausen syndrome (factitious disorder)]
K Kjiri, A Ajamieh, M Hansenne, et al.
Regulatory Peptides
|
April 29, 1993
Neurohypophyseal peptides and psychiatric diseases
J J Legros, M Ansseau, M Timsit-Berthier
Revue Medicale De Liege
|
August 6, 2010
[Recovering from depression: a matter of objective and determination]
W Pitchot, G Scantamburlo, E Pinto, et al.
Acta Psychiatrica Belgica
|
September 1, 1980
Biochemical and neuroendocrine approaches to a malignant syndrome of neuroleptics
M Ansseau, S Diricq, T Grisar, et al.
Acta Psychiatrica Belgica
|
September 1, 1983
Pilot study of a specific serotonergic antagonist, pirenperone, in the treatment of anxiety disorders
M Ansseau, A Doumont, D Thiry, et al.
Brain Research. Brain Research Reviews
|
November 10, 2005
Dopamine-glutamate reciprocal modulation of release and motor responses in the rat caudate-putamen and nucleus accumbens of "intact" animals
Hélène N David, Marc Ansseau, Jacques H Abraini
Revue Medicale De Liege
|
August 2, 2008
[The electroconvulsive therapy in 2008]
S Servais, M Ansseau, G Mikolajczak, et al.
Journal of Psychopharmacology (Oxford, England)
|
December 31, 2002
Venlafaxine: the relationship between dose, plasma concentration and clinical response in depressive patients
C Charlier, E Pinto, M Ansseau, et al.
Revue Medicale De Liege
|
March 13, 2010
[Inappropriate antidiuretic hormone secretion induced by sodium valproate]
E Bève, E Beck, E Pinto, et al.
Journal of Clinical Psychopharmacology
|
July 31, 2001
Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features
J D Guelfi, M Ansseau, L Timmerman, et al.
Page
of 27